GENOVA, Inc.

Business Details

Recognizing the extension of healthy life expectancy in a super-aged society as a social challenge, the company operates its proprietary media "Medical DOC," which distributes physician-supervised medical information articles. It provides paid referral article production and posting services to medical institutions, matching clinics seeking to attract patients with patients seeking information. Its competitive advantage stems from a nationwide sales network of 10 locations and article production expertise compliant with medical advertising regulations. In FY2026 (ending March 2026), segment sales were ¥5,035 million and segment profit was ¥1,785 million.

Recent Overview

Full-year FY2026 (ending March 2026) sales were ¥5,035 million, a significant decrease year on year

Full-year segment sales for FY2026 (ending March 2026) were ¥5,035 million (prior year: ¥6,267 million), and segment profit was ¥1,785 million (prior year: ¥3,143 million), both representing substantial declines from the prior period. This is believed to be mainly due to continued challenges in sales to new and existing customers, as page view (PV) numbers plateaued due to SEO impacts from Google algorithm updates. Note that the current correction to the financial results report relates to a change in the presentation classification of the cash flow statement and correction of an error in the allocation of segment assets; there is no change to the segment sales and profit figures for the Medical Platform Business.

Key Products

Growth Drivers

• Growth in the number of customer establishments and expansion of contract volume, driven by increases in monthly page views (PV)
• New products such as clinic tour reports are gaining traction with new customers, contributing to contract volume expansion
• Highly credible articles supervised by physicians and medical advisors are increasingly referenced by generative AI such as ChatGPT, resulting in a certain volume of landings via generative AI
• High barriers to entry due to a nationwide sales network of 10 locations and article production expertise compliant with medical advertising regulations
• Continued strong demand for patient acquisition among clinics, and ongoing demand in the advertising market targeting medical institutions

Risks

• PV numbers have plateaued due to SEO impacts from Google algorithm updates, leaving challenges in sales to both new and existing customers
• Changes in search patterns accompanying the spread of generative AI such as ChatGPT are acting as a headwind to PV growth
• Risk that delays or turnover among sales personnel could delay proposal activities and the acquisition of new business
• Risk that changes in or tightening of medical advertising regulations could necessitate changes to the content of article production and posting services
• Risk that continued flat PV numbers could make it difficult to maintain contract volume and unit prices, leading to lower profitability